Gallbladder cancer
All specialties
Gallbladder cancer
All specialties

Best Gallbladder cancer oncologists in Turkey: TOP 44 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Yusuf Acikgoz
Clinical oncologist
9 years of experience
4.5
3 reviews
Turkey, Ankara
Lokman Hekim University Ankara Hospital

Yusuf Acikgoz

Clinical oncologist
9 years of experience

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

  • 2004-2011: İnönü University Faculty of Medicine
  • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
  • 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

  • 2016-2017: Bingöl City Hospital, Internal Medicine
  • 2021-2022: Health Sciences University, Medical Oncology
  • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
  • 2023-2024: Ohio State University, Medical Oncology
  • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

  • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
  • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

  • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
  • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
  • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
  • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
  • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

  • Ongoing: ECFMG Certification
  • 2024: CITI Responsible Conduct of Research (The Ohio State University)
  • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
  • 2024: CITI Human Subjects Protection (The Ohio State University)
  • 2024: CITI Good Clinical Practice (The Ohio State University)
  • 2023: Occupational English Test (OET)
  • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
  • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
  • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

  • American Society of Clinical Oncology (ASCO) - 2022
  • Turkish Society of Medical Oncology - 2020
Read more

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

  • 2004-2011: İnönü University Faculty of Medicine
  • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
  • 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

  • 2016-2017: Bingöl City Hospital, Internal Medicine
  • 2021-2022: Health Sciences University, Medical Oncology
  • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
  • 2023-2024: Ohio State University, Medical Oncology
  • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

  • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
  • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

  • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
  • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
  • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
  • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
  • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

  • Ongoing: ECFMG Certification
  • 2024: CITI Responsible Conduct of Research (The Ohio State University)
  • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
  • 2024: CITI Human Subjects Protection (The Ohio State University)
  • 2024: CITI Good Clinical Practice (The Ohio State University)
  • 2023: Occupational English Test (OET)
  • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
  • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
  • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

  • American Society of Clinical Oncology (ASCO) - 2022
  • Turkish Society of Medical Oncology - 2020
Read more
Doctor Didem Karaçetin
Radiation oncologist
27 years of experience
4.7
18 reviews
Turkey, Istanbul
Neolife Medical Center

Doctor Didem Karaçetin

Radiation oncologist
27 years of experience

Areas of Interest

  • Breast Cancer
  • Prostate Cancer
  • Gastrointestinal System Tumors
  • Gynecological Tumors
  • Brain Tumors
  • Lung Cancer

Education
2021:

  • Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

  • Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

  • Associate Professor Title

1996:

  • Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

  • Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

  • Trakya University Faculty of Medicine

Work Experience
2024:

  • Neolife Medical Center – Biruni University

2021 – 2024:

  • Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

  • SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

  • Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

  • Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

  • Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

  • Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

  • Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Systems with Yıldız Technical University

2023:

  • Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

  • Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

  • Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

  • Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

  • Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

  • Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

  • President of Sakura Science and Academician Association (SABADER)

2023:

  • Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

  • Cam & Sakura Medical Journal, Section Editor

2018:

  • Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

  • Turkish Radiation Oncology Association

1989:

  • Turkish Medical Association

Scientific Works

  • A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
  • A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
  • A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
  • A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s
Read more

Areas of Interest

  • Breast Cancer
  • Prostate Cancer
  • Gastrointestinal System Tumors
  • Gynecological Tumors
  • Brain Tumors
  • Lung Cancer

Education
2021:

  • Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

  • Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

  • Associate Professor Title

1996:

  • Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

  • Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

  • Trakya University Faculty of Medicine

Work Experience
2024:

  • Neolife Medical Center – Biruni University

2021 – 2024:

  • Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

  • SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

  • Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

  • Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

  • Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

  • Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

  • Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Systems with Yıldız Technical University

2023:

  • Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

  • Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

  • Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

  • Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

  • Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

  • Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

  • President of Sakura Science and Academician Association (SABADER)

2023:

  • Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

  • Cam & Sakura Medical Journal, Section Editor

2018:

  • Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

  • Turkish Radiation Oncology Association

1989:

  • Turkish Medical Association

Scientific Works

  • A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
  • A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
  • A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
  • A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s
Read more
roman Ibrahimov
Radiation oncologist
27 years of experience
4.7
18 reviews
Turkey, Istanbul
Neolife Medical Center

roman Ibrahimov

Radiation oncologist
27 years of experience

Education:

  • 2008 – 2012: Marmara University School of Medicine (Specialization Training)
  • 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

  • 2012 – Present: Neolife Medical Center

Memberships:

  • Turkish Society of Radiation Oncology

Scientific Works:

2014:

  • 11th National Radiation Oncology Congress
    • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
    • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

  • 1st Evidence-Based Medicine Course
    • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."
Read more

Education:

  • 2008 – 2012: Marmara University School of Medicine (Specialization Training)
  • 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

  • 2012 – Present: Neolife Medical Center

Memberships:

  • Turkish Society of Radiation Oncology

Scientific Works:

2014:

  • 11th National Radiation Oncology Congress
    • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
    • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

  • 1st Evidence-Based Medicine Course
    • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."
Read more
Turkan Ozturk Topcu
Clinical oncologist
15 years of experience
Turkey, Istanbul
Biruni University Hospital

Turkan Ozturk Topcu

Clinical oncologist
15 years of experience

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

 

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

 

Medical Intrests

  • Breast Cancer
  • Lung Cancer
  • Colon Cancer
  • Stomach Cancer
  • Rectal Cancer
  • Ovarian Cancer
  • Liver Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Kidney Cancer
  • Larynx Cancer - Cancer of the Larynx
  • Thyroid Cancer
  • Head and Neck Cancers
  • Gynaecological Cancers
  • Pancreatic Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Uterine Cancer
  • Brain Cancers - Brain Tumours
  • Soft Tissue Cancer - Sarcomas
  • Prostate Cancer
  • Bladder Cancer
  • Bile Tract Cancer
  • Testicular Cancer
  • Cervical Cancer
  • Mouth, Tongue, Lip Cancers
  • Gastrointestinal System Cancers
  • Bone Tumours
  • Trachea and Bronchial Cancers
  • Skin Cancers - Skin Cancers
  • Skeletal System Tumours
  • Gallbladder Cancer
  • Mesothelioma
Read more

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

 

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

 

Medical Intrests

  • Breast Cancer
  • Lung Cancer
  • Colon Cancer
  • Stomach Cancer
  • Rectal Cancer
  • Ovarian Cancer
  • Liver Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Kidney Cancer
  • Larynx Cancer - Cancer of the Larynx
  • Thyroid Cancer
  • Head and Neck Cancers
  • Gynaecological Cancers
  • Pancreatic Cancer
  • Oesophageal Cancer - Oesophageal Cancer
  • Uterine Cancer
  • Brain Cancers - Brain Tumours
  • Soft Tissue Cancer - Sarcomas
  • Prostate Cancer
  • Bladder Cancer
  • Bile Tract Cancer
  • Testicular Cancer
  • Cervical Cancer
  • Mouth, Tongue, Lip Cancers
  • Gastrointestinal System Cancers
  • Bone Tumours
  • Trachea and Bronchial Cancers
  • Skin Cancers - Skin Cancers
  • Skeletal System Tumours
  • Gallbladder Cancer
  • Mesothelioma
Read more
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.